ARS Pharmaceuticals Inc (SPRY)
8.92
+0.09
(+1.02%)
USD |
NASDAQ |
May 22, 16:00
8.92
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Price: 8.92 for May 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 21, 2024 | 9.13 | 9.15 | 8.81 | 8.83 | 264663.0 |
May 20, 2024 | 9.09 | 9.31 | 9.075 | 9.19 | 315140.0 |
May 17, 2024 | 9.13 | 9.25 | 8.99 | 9.03 | 292480.0 |
May 16, 2024 | 8.92 | 9.14 | 8.79 | 9.10 | 404491.0 |
May 15, 2024 | 9.15 | 9.16 | 8.83 | 8.88 | 301241.0 |
May 14, 2024 | 8.94 | 9.06 | 8.88 | 8.98 | 357043.0 |
May 13, 2024 | 8.72 | 9.02 | 8.72 | 8.89 | 322492.0 |
May 10, 2024 | 8.93 | 9.00 | 8.59 | 8.74 | 306001.0 |
May 09, 2024 | 9.06 | 9.19 | 8.72 | 8.80 | 332315.0 |
May 08, 2024 | 9.35 | 9.553 | 8.98 | 9.06 | 352698.0 |
May 07, 2024 | 9.44 | 9.51 | 9.14 | 9.47 | 474003.0 |
May 06, 2024 | 9.75 | 9.80 | 9.10 | 9.45 | 401258.0 |
May 03, 2024 | 9.66 | 9.76 | 9.39 | 9.75 | 364184.0 |
May 02, 2024 | 9.35 | 9.51 | 8.94 | 9.46 | 575509.0 |
May 01, 2024 | 8.73 | 9.62 | 8.67 | 9.33 | 1.110M |
Apr 30, 2024 | 8.58 | 8.79 | 8.51 | 8.70 | 335349.0 |
Apr 29, 2024 | 8.47 | 8.72 | 8.41 | 8.60 | 364643.0 |
Apr 26, 2024 | 8.17 | 8.66 | 8.10 | 8.35 | 520298.0 |
Apr 25, 2024 | 8.09 | 8.19 | 7.66 | 8.09 | 534709.0 |
Apr 24, 2024 | 8.46 | 8.545 | 8.155 | 8.26 | 334679.0 |
Apr 23, 2024 | 8.44 | 8.83 | 8.309 | 8.50 | 510439.0 |
Apr 22, 2024 | 8.57 | 8.60 | 8.145 | 8.21 | 394656.0 |
Apr 19, 2024 | 8.41 | 8.65 | 8.25 | 8.47 | 487875.0 |
Apr 18, 2024 | 9.02 | 9.19 | 8.38 | 8.44 | 918109.0 |
Apr 17, 2024 | 9.28 | 9.28 | 8.88 | 9.06 | 456563.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.92
Minimum
Sep 20 2023
10.22
Maximum
Mar 28 2024
6.836
Average
6.90
Median
Aug 24 2023
Price Benchmarks
KalVista Pharmaceuticals Inc | 11.73 |
Phathom Pharmaceuticals Inc | 10.34 |
Vera Therapeutics Inc | 37.98 |
Nuvalent Inc | 69.83 |
CEL-SCI Corp | 1.30 |
Price Related Metrics
Price to Book Value | 3.861 |
Earnings Yield | -5.83% |
Market Cap | 864.31M |